Neurogenic Orthostatic Hypotension
📧 Sign up to get email alerts when something new happens for Neurogenic Orthostatic Hypotension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients [EARLY_Phase 1]
Early-phase trial comparing midodrine to abdominal compression in autonomic failure patients assessing cardiovascular risk markers.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy [Phase 3]
A Phase 3 trial update evaluating the efficacy and durability of Ampreloxetine for treating symptomatic neurogenic orthostatic hypotension i…
-
CLINICAL_TRIALS trial_result · 2023-10-02Clinical Trial Update: Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension [Phase 4]
Phase 4 trial update reporting efficacy and tolerance of Flucortac in patients with neurogenic orthostatic hypotension.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension [Phase 4]
Phase 4 trial update showing sustained effect of droxidopa in symptomatic neurogenic orthostatic hypotension.
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) [Phase 2]
Phase 2 clinical trial update for TD-9855 in neurogenic orthostatic hypotension (nOH) completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) [Phase 2]
Phase 2 clinical trial update for norepinephrine transporter blockade in neurogenic orthostatic hypotension has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure [Phase 3]
Phase 3 trial assessing ampRELOXetine (TD-9855) for symptomatic neurogenic orthostatic hypotension due to primary autonomic failure has comp…
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Brain Perfusion & Oxygenation in Parkinson's Disease With NOH [Phase 4]
Phase 4 trial update on brain perfusion and oxygenation in Parkinson's disease with neurogenic orthostatic hypotension has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH) [Phase 2]
Phase 2 trial evaluating L-Dihydroxyphenylserine (L-DOPS) for reducing falls in patients with neurogenic orthostatic hypotension, Parkinson …
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH [Phase 4]
Phase 4 trial evaluating the efficacy and safety of midodrine and atomoxetine for neurogenic orthostatic hypotension has been completed.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study [Phase 4]
A Phase 4 randomized trial reports on treatment and prognosis for neurogenic orthostatic hypotension, with completed results available.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy [Phase 3]
Phase 3 study of droxidopa in symptomatic neurogenic orthostatic hypotension, including participants with Parkinson's disease, multiple syst…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension [Phase 4]
Phase 4 trial update evaluating the benefit of midodrine in neurogenic orthostatic hypotension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: A Study for Patients With Neurogenic Orthostatic Hypotension [Phase 4]
Phase 4 trial update for patients with neurogenic orthostatic hypotension; study completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome [Phase 2]
Phase 2 study evaluating droxidopa for chronic fatigue syndrome with orthostatic symptoms was terminated; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) [Phase 3]
This update reports the Phase 3 results of droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease [Phase 3]
Phase 3 two-part trial (306A/306B) evaluated droxidopa for neurogenic orthostatic hypotension in Parkinson's disease; the study completed an…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa [Phase 3]
Phase 3 clinical trial of droxidopa for neurogenic orthostatic hypotension has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) [Phase 3]
Open-label Phase 3 study of droxidopa in neurogenic orthostatic hypotension has completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304) [Phase 3]
Phase 3 clinical study of droxidopa (NOH) completed; results posted in 2014 for patients with neurogenic orthostatic hypotension and related…
-
CLINICAL_TRIALS trial_result · 2008-10-01Clinical Trial Update: Fipamezole in Neurogenic Orthostatic Hypotension [Phase 2]
Phase 2 clinical trial update on fipamezole for symptomatic neurogenic orthostatic hypotension, with associated conditions including Parkins…